Literature DB >> 6620982

Antibodies to neurofibrillary tangles of Alzheimer's disease raised from human and animal neurofilament fractions.

P Gambetti, L Autilio-Gambetti, G Perry, G Shecket, R C Crane.   

Abstract

Antibodies reacting with neurofibrillary tangles (NFT) of Alzheimer's disease were consistently obtained using neurofilament (NF) fractions as antigen. NF fractions were obtained from normal human spinal roots or guinea pig peripheral nerves and used to immunize BALB/c mice. Mice receiving a total dose of 300 to 600 micrograms of protein developed antibodies that were indistinguishable with immunostaining of tissues and of polypeptides separated on sodium dodecyl sulfate-polyacrylamide electrophoresis gels. These antibodies reacted with NFT from cases of Alzheimer's disease and with NFT induced with aluminum, as well as with structures rich in NF such as central and peripheral axons and cerebellar basket fibers. When used to immunostain polypeptides separated by sodium dodecyl sulfate-polyacrylamide electrophoresis, all antisera recognized the three NF subunits. Absorption of the antisera with 5 micrograms/ml of purified human NF proteins blocked immunostaining of Alzheimer's NFT. It is concluded that human and animal NF fractions are excellent antigens to produce antibodies that consistently react with NFT of Alzheimer's disease. The present findings further support existing evidence that the paired helical filaments of Alzheimer's disease share antigenic determinants with normal NF.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6620982

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  10 in total

1.  Immune electron microscopic characterization of monoclonal antibodies to Alzheimer neurofibrillary tangles.

Authors:  M A Wrzolek; P A Merz; R Kascsak; I Grundke-Iqbal; K Iqbal; R Rubenstein; M Tonna-DeMasi; N L Goller; P Mehta; H M Wisniewski
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

2.  Alzheimer neurofibrillary tangles contain phosphorylated and hidden neurofilament epitopes.

Authors:  M C Haugh; A Probst; J Ulrich; J Kahn; B H Anderton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-11       Impact factor: 10.154

3.  Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs.

Authors:  Parvathi Rudrabhatla; Howard Jaffe; Harish C Pant
Journal:  FASEB J       Date:  2011-08-09       Impact factor: 5.191

4.  Intracellular neurofibrillary tangle-like aggregations. A constantly present amyloid alteration in the aging choroid plexus.

Authors:  L Eriksson; P Westermark
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

Review 5.  Molecular neuropathology of Alzheimer's disease: in situ hybridization studies.

Authors:  M Goedert; M G Spillantini
Journal:  Cell Mol Neurobiol       Date:  1990-03       Impact factor: 5.046

6.  Paired helical filaments from Alzheimer disease patients contain cytoskeletal components.

Authors:  G Perry; N Rizzuto; L Autilio-Gambetti; P Gambetti
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

7.  Dementia of Alzheimer type (DAT)--a review of its morbid anatomy.

Authors:  J Ulrich; A Probst; B H Anderton; J Kahn
Journal:  Klin Wochenschr       Date:  1986-02-03

8.  Filaments of Pick's bodies contain altered cytoskeletal elements.

Authors:  G Perry; D Stewart; R Friedman; V Manetto; L Autilio-Gambetti; P Gambetti
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

9.  Alzheimer disease tangles share immunological similarities with multiphosphorylation repeats in the two large neurofilament proteins.

Authors:  V M Lee; L Otvos; M L Schmidt; J Q Trojanowski
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

10.  Relationship of aluminum to Alzheimer's disease.

Authors:  D P Perl
Journal:  Environ Health Perspect       Date:  1985-11       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.